Immune responses associated with susceptibility of C57BL/10 mice to Leishmania amazonensis
- PMID: 8514400
- PMCID: PMC280944
- DOI: 10.1128/iai.61.7.2952-2959.1993
Immune responses associated with susceptibility of C57BL/10 mice to Leishmania amazonensis
Abstract
Leishmaniae are protozoans which, depending upon both the host and parasite species, can cause either a healing or nonhealing infection. While C57BL/10 mice are able to heal following infection with Leishmania major, they fail to heal following infection with Leishmania amazonensis. In order to address the role of Th1 and Th2 cell responses in the outcome of these infections in C57BL/10 mice, gamma interferon (IFN-gamma) and interleukin-4 (IL-4) production was assessed. While cells from L. major-infected C57BL/10 mice produced high levels of IFN-gamma, cells from L. amazonensis-infected animals produced little or no IFN-gamma. On the other hand, IL-4 was produced only by cells from L. amazonensis-infected C57BL/10 mice, but this production was restricted to the first few weeks of infection. Later in infection, when lesions were evident, no IL-4 was detected. Treatment of BALB/c mice with a monoclonal antibody (11B11) directed against IL-4 induced a dramatic reduction in L. amazonensis lesions. This reduction was associated with a decrease in IL-4 levels and an increase in IFN-gamma production. However, only a slight reduction in lesion sizes and parasite numbers was observed when anti-IL-4-treated C57BL/10 mice were infected with L. amazonensis. These results suggest that IL-4 may have an important role in mediating susceptibility to L. amazonensis in BALB/c mice, as previously demonstrated for L. major. More importantly, however, the data suggest that susceptibility to L. amazonensis in C57BL/10 mice is due to the absence of a Th1 cell response, rather than to the presence of a Th2 cell response.
Similar articles
-
Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40.Immunol Lett. 2006 May 15;105(1):38-47. doi: 10.1016/j.imlet.2005.12.002. Epub 2006 Jan 13. Immunol Lett. 2006. PMID: 16466810
-
The role of interleukin-10 in susceptibility of BALB/c mice to infection with Leishmania mexicana and Leishmania amazonensis.J Immunol. 2003 Oct 1;171(7):3705-10. doi: 10.4049/jimmunol.171.7.3705. J Immunol. 2003. PMID: 14500669
-
IL-4-independent inhibition of IL-12 responsiveness during Leishmania amazonensis infection.J Immunol. 2000 Jul 1;165(1):364-72. doi: 10.4049/jimmunol.165.1.364. J Immunol. 2000. PMID: 10861073
-
Anti-leishmania effector functions of CD4+ Th1 cells and early events instructing Th2 cell development and susceptibility to Leishmania major in BALB/c mice.Adv Exp Med Biol. 1998;452:53-60. doi: 10.1007/978-1-4615-5355-7_7. Adv Exp Med Biol. 1998. PMID: 9889959 Review.
-
Chronic infection by Leishmania amazonensis mediated through MAPK ERK mechanisms.Immunol Res. 2014 Aug;59(1-3):153-65. doi: 10.1007/s12026-014-8535-y. Immunol Res. 2014. PMID: 24838145 Free PMC article. Review.
Cited by
-
Sphingolipid degradation in Leishmania (Leishmania) amazonensis.PLoS Negl Trop Dis. 2012;6(12):e1944. doi: 10.1371/journal.pntd.0001944. Epub 2012 Dec 20. PLoS Negl Trop Dis. 2012. PMID: 23285302 Free PMC article.
-
Host-Directed Therapies for Cutaneous Leishmaniasis.Front Immunol. 2021 Mar 26;12:660183. doi: 10.3389/fimmu.2021.660183. eCollection 2021. Front Immunol. 2021. PMID: 33841444 Free PMC article. Review.
-
An 8-hydroxyquinoline-containing polymeric micelle system is effective for the treatment of murine tegumentary leishmaniasis.Parasitol Res. 2016 Nov;115(11):4083-4095. doi: 10.1007/s00436-016-5181-4. Epub 2016 Jul 1. Parasitol Res. 2016. PMID: 27365053
-
Antileishmanial activity of a new chloroquine analog in an animal model of Leishmania panamensis infection.Int J Parasitol Drugs Drug Resist. 2020 Dec;14:56-61. doi: 10.1016/j.ijpddr.2020.08.002. Epub 2020 Aug 15. Int J Parasitol Drugs Drug Resist. 2020. PMID: 32950020 Free PMC article.
-
One Health Approach to Leishmaniases: Understanding the Disease Dynamics through Diagnostic Tools.Pathogens. 2020 Oct 1;9(10):809. doi: 10.3390/pathogens9100809. Pathogens. 2020. PMID: 33019713 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases